Related Party Transactions |
9 Months Ended | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | |||||||||||||||||||||||||
| Related Party Transactions [Abstract] | |||||||||||||||||||||||||
| Related Party Transactions |
Note 11 – Related Party Transactions
2026 Series D Financing
On July 10, 2026, HEZBAY Holdings LLC (“HEZBAY”), a current holder of more than of the Company’s common stock, purchased 500 shares of Series D Preferred Stock and Series D Warrants to purchase 95,239 shares of common stock in the Series D Financing. See Note 9 for additional information.
2026 Warrant Inducement
On July 10, 2026, the Company entered into the Inducement Letters with the Warrant Holders of its Existing Warrants. Pursuant to the Inducement Letters, the Warrant Holders agreed to exercise for cash all or a portion of their 2025 Warrants at the current exercise price of $5.25 per share in consideration for the Company’s agreement to issue New Warrants to purchase up to 499,107 shares of common stock ( of the number of shares of common stock issued pursuant to each such exercise of 2025 Warrants), in a private placement in accordance with Section 4(a)(2) of the Securities Act. The Warrant Inducement closed on July 10, 2026. See Note 9 for additional information.
Certain holders of the Company’s Series C Convertible Preferred Stock and 2025 Warrants are related parties. During the three months ended September 30, 2026, the Company recognized deemed dividends of $3.6 million associated with the down-round adjustments to the Series C Convertible Preferred Stock and 2025 Warrants, of which $1.7 million was attributable to related parties. In addition, the Company recognized deemed dividends of $3.5 million associated with the Warrant Inducement, of which $1.7 million was attributable to related parties.
2025 Offering
On February 13, 2025, the Company entered into the February 2025 Agreement with certain investors pursuant to which the Company agreed to issue and sell, in a private placement, an aggregate of shares of Series C Preferred Stock, initially convertible into up to shares of common stock, with a stated value of $ per share, and 2025 Warrants to purchase up to an aggregate of of the shares of common stock into which the shares of Series C Preferred Stock are initially convertible, or 750,854 shares of common stock, for an offering price of $ per share of Series C Preferred Stock and accompanying 2025 Warrants.
Pursuant to the February 2025 Agreement the Company issued and sold, in an initial closing, shares of Series C Preferred Stock, initially convertible into up to shares of common stock, and accompanying 2025 Warrants, initially exercisable for up to shares of common stock, for gross proceeds of $1.65 million. On April 4, 2025, the Company obtained stockholder approval for the issuance of the Series C Preferred Stock and 2025 Warrants, as required by the rules and regulations of NYSE American, including Section 713 of the NYSE American Company Guide, and issued and sold, in a second closing, an additional shares of Series C Preferred Stock, initially convertible into up to shares of common stock, and accompanying 2025 Warrants, initially exercisable for up to shares of common stock, for gross proceeds of $1.65 million.
|